| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/20/2006 | WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/20/2006 | WO2006040568A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | WO2006040526A1 Quinazoline derivatives for use against cancer |
| 04/20/2006 | WO2006040522A1 Quinoline derivatives |
| 04/20/2006 | WO2006040465A2 Novel product, method and intermediates for the preparation of azetidine derivatives |
| 04/20/2006 | WO2006040329A1 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/20/2006 | WO2006040300A1 4-cycloalkyl-pyrimidine-2-carbonitrile derivatives |
| 04/20/2006 | WO2006040192A1 Pyrrolidine derivatives as histamine receptors ligands |
| 04/20/2006 | WO2006040182A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040177A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| 04/20/2006 | WO2006040113A2 Heterocyclic diamide insecticidal agents |
| 04/20/2006 | WO2006040056A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 04/20/2006 | WO2006039977A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 04/20/2006 | WO2006025979A9 Modulators of nuclear receptors |
| 04/20/2006 | WO2006021002A3 Compounds useful for inhibiting chk1 |
| 04/20/2006 | WO2006015194A3 Preparation of pyridonecarboxylic acid antibacterials |
| 04/20/2006 | WO2006013393A3 Quinoline derivatives as neurokinin receptor antagonists |
| 04/20/2006 | WO2005117882A8 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 04/20/2006 | WO2005115398A3 Hiv integrase inhibitors |
| 04/20/2006 | WO2005094514A3 Heteroaryl piperidine glycine transporter inhibitors |
| 04/20/2006 | WO2005040155A8 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 04/20/2006 | WO2005016913A8 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| 04/20/2006 | US20060084812 Purification of impure materials using non-aqueous solvents |
| 04/20/2006 | US20060084811 Method for the synthesis of a benzimidazole compound |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084807 Novel denzamide derivatives and process for production thereof |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084682 e.g. 5-{2-[6-(3,4-Dichloro-phenyl)-pyridin-2-yl]-1H-benzoimidazol-5-ylmethylene}-2-thioxo-thiozolidin; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
| 04/20/2006 | US20060084681 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 04/20/2006 | US20060084679 Quinoline derivatives as H3R inverse agonists |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084651 Chemical compounds |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | US20060084647 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof |
| 04/20/2006 | US20060084644 Atherosclerosis, unwanted cellular growth or cellular proliferation, diabetes, inflammatory conditions and vascular occlusive pathologic conditions; novel compound 1-[4-(4-Hydroxy-6'-phenyl-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-2'-ylamino)-phenyl]-ethanone; modulation of glycosidase enzymes |
| 04/20/2006 | US20060084612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 04/20/2006 | US20060083774 Neurophilin ligands for treating ocular conditions |
| 04/20/2006 | US20060083688 Optical determination of glucose utilizing boronic acid adducts |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | DE102004050196A1 Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted 2-pyridone derivatives, processes for their preparation and their use as a medicament |
| 04/20/2006 | CA2584185A1 Heterocyclic substituted bisarylurea derivates as kinase inhibitors |
| 04/20/2006 | CA2583992A1 Novel product, method and intermediates for the preparation of azetidine derivatives |
| 04/20/2006 | CA2583983A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583967A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583845A1 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 04/20/2006 | CA2583292A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 04/20/2006 | CA2583096A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | CA2582954A1 Salt and crystalline forms thereof of 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxyazetidin-1-yl)-4-oxo-3-quinolinecarboxylic acid |
| 04/20/2006 | CA2582933A1 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/20/2006 | CA2582459A1 Substituted sulfones and methods of use |
| 04/20/2006 | CA2582202A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | CA2581516A1 Quinazoline derivatives |
| 04/20/2006 | CA2580497A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | CA2580419A1 Novel insecticides |
| 04/19/2006 | EP1647548A1 Dictionic bishydrazones, dyeingcompositions containig at least one of these compounds, process of their preparation and uses thereoff |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1646626A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646625A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646624A1 Indoles useful in the treatment of inflammation |
| 04/19/2006 | EP1646623A2 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/19/2006 | EP1646622A1 Tacrine derivatives as inhibitors of acetylcholinesterase |
| 04/19/2006 | EP1646621A2 Novel azaheterocyclic amides useful for treating pain |
| 04/19/2006 | EP1646620A1 Substituted piperidines as histamine h3 receptor ligands |
| 04/19/2006 | EP1646615A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 04/19/2006 | EP1646613A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 04/19/2006 | EP1646610A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 04/19/2006 | EP1646382A2 Compounds, compositions and methods |
| 04/19/2006 | EP1556371B1 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1412331B1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1373396A4 Highly nucleated thermoplastic articles |
| 04/19/2006 | EP1363883B1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith |
| 04/19/2006 | EP1349833B1 Indole and dihydroindole derivatives |
| 04/19/2006 | EP1339706B1 N-type calcium channel antagonists for the treatment of pain |
| 04/19/2006 | EP1339695B1 Farnesyltransferase inhibitors |
| 04/19/2006 | EP1339407B1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1255537B1 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/19/2006 | EP1237886B1 Meglumine salt of a specific quinolinecarboxylic acid compound active on nmda receptors |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | EP0859772B1 Herbicidal substituted pyridine compounds |
| 04/19/2006 | CN1761661A Pharmaceutical preparations containing arginine amides |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/19/2006 | CN1760192A Cationic diazo compounds, compositions comprising them, methods for dyeing and kit |
| 04/19/2006 | CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/18/2006 | US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 04/18/2006 | US7030241 Mesylates of piperazine derivatives and process for their preparation |